Learn about LipiGesic-M
LipiGesic-M has been declared an excellent first-line therapy for the treatement of acute migraine and associated symptoms by world-class headache experts. It has superior efficacy and an excellent safety profile with no known drug interactions. Each patented dose is individually pre-measured for sublingual delivery so there’s no measuring or mess. It is as effective as the top selling prescription migraine medication without the debilitating side effects and the high cost. LipiGesic M does not cause rebound or medication overuse headaches. Learn More Request A Sample
PuraMed BioScience, Inc. emphasizes science as the key to success. PuraMed uses a unique sublingual (under-the-tongue) delivery system utilizing the capillary structure under the tongue which is very close to the surface allowing for fast absorption and action. Sublingual delivery bypasses the liver and digestive system, which allows for smaller dosage requirements. For this reason, the Company believes its products will outperform other drugs currently available in the U.S.Read More
Dr. Cady Explains LipiGesic M Clinical Trial
An estimated 18% of women and 6% of men experience migraines; it is the cause of most medical visits for headache. Headache expert, Dr. Roger Cady, discusses the results of treatment of migraine headache with feverfew and ginger, the active ingredients in the migraine treatment LipiGesic-M.
PMBS CEO Russ Mitchell discusses the state of the migraine market on the Big Biz Show
Migraine affects 50 million people in the United States and costs American industries $50 billiion in lost productivity and healthcare costs. PuraMed BioScience CEO Russ Mitchell discusses the migraine market and LipiGesic M as a migraine treatment with Bob "Sully" Sullivan.
Contact a Representative
Would you like to speak to a PuraMed representative?